Market Value147,932,764
Total Holdings59
File Date2024-12-13
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Note this is an amended filing that contain additional holdings that were omitted from a previous filing. This is not likely to be an accurate picture of the total holdings of this firm.

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACRV / Acrivon Therapeutics, Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
IRON / Disc Medicine, Inc.
APRE / Aprea Therapeutics, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
INSM / Insmed Incorporated
STOK / Stoke Therapeutics, Inc.
ALGN / Align Technology, Inc.
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
GH / Guardant Health, Inc.
AGIO / Agios Pharmaceuticals, Inc.
NUVL / Nuvalent, Inc.
SRRK / Scholar Rock Holding Corporation
RLAY / Relay Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
ETNB / 89bio, Inc.
BMY / Bristol-Myers Squibb Company
MRSN / Mersana Therapeutics, Inc.
GERN / Geron Corporation
VRDN / Viridian Therapeutics, Inc.
US48576UAA43 / Karyopharm Therapeutics Inc
TECX / Tectonic Therapeutic, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
LPTX / Leap Therapeutics, Inc.
PLRX / Pliant Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
BPMC / Blueprint Medicines Corporation
STAA / STAAR Surgical Company
GKOS / Glaukos Corporation
RVNC / Revance Therapeutics, Inc.
CI / The Cigna Group
QTRX / Quanterix Corporation
AMGN / Amgen Inc.
ADAG / Adagene Inc. - Depositary Receipt (Common Stock)
PROC / Procaps Group S.A.
SWTX / SpringWorks Therapeutics, Inc.
GOSS / Gossamer Bio, Inc.
ISRG / Intuitive Surgical, Inc.
AKRO / Akero Therapeutics, Inc.
LLY / Eli Lilly and Company
NTRA / Natera, Inc.
GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
ALVO / Alvotech
ESTA / Establishment Labs Holdings Inc.
VYNE / VYNE Therapeutics Inc.
CYTK / Cytokinetics, Incorporated
APLS / Apellis Pharmaceuticals, Inc.
BIIB / Biogen Inc.
PACB / Pacific Biosciences of California, Inc.
TGTX / TG Therapeutics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
RZLT / Rezolute, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
TARS / Tarsus Pharmaceuticals, Inc.
BBIO / BridgeBio Pharma, Inc.
KURA / Kura Oncology, Inc.
LXEO / Lexeo Therapeutics, Inc.